Global Raloxifene Hydrochloride Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	161 Pages	TechNavio	January, 2024	INF18455791

Best Price Guarantee
Price	from $2,500
Length	161 Pages
Publisher	TechNavio
Published Date	January, 2024
SKU	INF18455791

Global Raloxifene Hydrochloride Market 2024-2028

The raloxifene hydrochloride market is forecasted to grow by USD 637.31 mn during 2023-2028, accelerating at a CAGR of 7.93% during the forecast period. The report on the raloxifene hydrochloride market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of osteoporosis driving market demand, the growing aging population, and growing applications in the pharmaceutical industry.

Technavio's raloxifene hydrochloride market is segmented as below:

By End-user

Pharmaceutical
Chemical industry

By Type

Tablet
Capsule

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing use of raloxifene hcl for prevention of breast cancer as one of the prime reasons driving the raloxifene hydrochloride market growth during the next few years. Also, reimbursement programs and coverage of drugs by health insurance and growing awareness of women's health will lead to sizable demand in the market.

The report on the raloxifene hydrochloride market covers the following areas:

Raloxifene hydrochloride market sizing
Raloxifene hydrochloride market forecast
Raloxifene hydrochloride market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading raloxifene hydrochloride market vendors that include Amneal Pharmaceuticals Inc., Blanver, Cadila Pharmaceuticals Ltd., Cipla Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Enzo Biochem Inc., Glenmark Pharmaceuticals Ltd., Merck KGaA, Midas Pharma GmbH, Santa Cruz Biotechnology Inc., Taj Pharmaceutical Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Tokyo Chemical Industry Co. Ltd.. Also, the raloxifene hydrochloride market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Type; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global raloxifene hydrochloride market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global raloxifene hydrochloride market 2018 - 2022 ($ million); 4.2 End-user Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Type Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 30: Chart on End-user - Market share 2023-2028 (%); Exhibit 31: Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Exhibit 32: Chart on Comparison by End-user; Exhibit 33: Data Table on Comparison by End-user; 6.3 Pharmaceutical - Market size and forecast 2023-2028; Exhibit 34: Chart on Pharmaceutical - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Pharmaceutical - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Pharmaceutical - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Pharmaceutical - Year-over-year growth 2023-2028 (%); 6.4 Chemical industry - Market size and forecast 2023-2028; Exhibit 38: Chart on Chemical industry - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Chemical industry - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Chemical industry - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Chemical industry - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by End-user; Exhibit 42: Market opportunity by End-user ($ million); Exhibit 43: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Exhibit 44: Chart on Type - Market share 2023-2028 (%); Exhibit 45: Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Exhibit 46: Chart on Comparison by Type; Exhibit 47: Data Table on Comparison by Type; 7.3 Tablet - Market size and forecast 2023-2028; Exhibit 48: Chart on Tablet - Market size and forecast 2023-2028 ($ million); Exhibit 49: Data Table on Tablet - Market size and forecast 2023-2028 ($ million); Exhibit 50: Chart on Tablet - Year-over-year growth 2023-2028 (%); Exhibit 51: Data Table on Tablet - Year-over-year growth 2023-2028 (%); 7.4 Capsule - Market size and forecast 2023-2028; Exhibit 52: Chart on Capsule - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on Capsule - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on Capsule - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Capsule - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Type; Exhibit 56: Market opportunity by Type ($ million); Exhibit 57: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 61: Chart on Geographic comparison; Exhibit 62: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 99: Market opportunity By Geographical Landscape ($ million); Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 101: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 102: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 103: Overview on factors of disruption; 11.4 Industry risks; Exhibit 104: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 105: Vendors covered; 12.2 Market positioning of vendors; Exhibit 106: Matrix on vendor position and classification; 12.3 Amneal Pharmaceuticals Inc.; Exhibit 107: Amneal Pharmaceuticals Inc. - Overview; Exhibit 108: Amneal Pharmaceuticals Inc. - Business segments; Exhibit 109: Amneal Pharmaceuticals Inc. - Key news; Exhibit 110: Amneal Pharmaceuticals Inc. - Key offerings; Exhibit 111: Amneal Pharmaceuticals Inc. - Segment focus; 12.4 Blanver; Exhibit 112: Blanver - Overview; Exhibit 113: Blanver - Product / Service; Exhibit 114: Blanver - Key offerings; 12.5 Cadila Pharmaceuticals Ltd.; Exhibit 115: Cadila Pharmaceuticals Ltd. - Overview; Exhibit 116: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibit 117: Cadila Pharmaceuticals Ltd. - Key offerings; 12.6 Cipla Ltd.; Exhibit 118: Cipla Ltd. - Overview; Exhibit 119: Cipla Ltd. - Business segments; Exhibit 120: Cipla Ltd. - Key news; Exhibit 121: Cipla Ltd. - Key offerings; Exhibit 122: Cipla Ltd. - Segment focus; 12.7 Dr Reddys Laboratories Ltd.; Exhibit 123: Dr Reddys Laboratories Ltd. - Overview; Exhibit 124: Dr Reddys Laboratories Ltd. - Business segments; Exhibit 125: Dr Reddys Laboratories Ltd. - Key offerings; Exhibit 126: Dr Reddys Laboratories Ltd. - Segment focus; 12.8 Eli Lilly and Co.; Exhibit 127: Eli Lilly and Co. - Overview; Exhibit 128: Eli Lilly and Co. - Product / Service; Exhibit 129: Eli Lilly and Co. - Key news; Exhibit 130: Eli Lilly and Co. - Key offerings; 12.9 Enzo Biochem Inc.; Exhibit 131: Enzo Biochem Inc. - Overview; Exhibit 132: Enzo Biochem Inc. - Business segments; Exhibit 133: Enzo Biochem Inc. - Key offerings; Exhibit 134: Enzo Biochem Inc. - Segment focus; 12.10 Glenmark Pharmaceuticals Ltd.; Exhibit 135: Glenmark Pharmaceuticals Ltd. - Overview; Exhibit 136: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibit 137: Glenmark Pharmaceuticals Ltd. - Key offerings; 12.11 Merck KGaA; Exhibit 138: Merck KGaA - Overview; Exhibit 139: Merck KGaA - Business segments; Exhibit 140: Merck KGaA - Key news; Exhibit 141: Merck KGaA - Key offerings; Exhibit 142: Merck KGaA - Segment focus; 12.12 Midas Pharma GmbH; Exhibit 143: Midas Pharma GmbH - Overview; Exhibit 144: Midas Pharma GmbH - Product / Service; Exhibit 145: Midas Pharma GmbH - Key offerings; 12.13 Santa Cruz Biotechnology Inc.; Exhibit 146: Santa Cruz Biotechnology Inc. - Overview; Exhibit 147: Santa Cruz Biotechnology Inc. - Product / Service; Exhibit 148: Santa Cruz Biotechnology Inc. - Key offerings; 12.14 Taj Pharmaceutical Ltd.; Exhibit 149: Taj Pharmaceutical Ltd. - Overview; Exhibit 150: Taj Pharmaceutical Ltd. - Product / Service; Exhibit 151: Taj Pharmaceutical Ltd. - Key offerings; 12.15 Teva Pharmaceutical Industries Ltd.; Exhibit 152: Teva Pharmaceutical Industries Ltd. - Overview; Exhibit 153: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibit 154: Teva Pharmaceutical Industries Ltd. - Key news; Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibit 156: Teva Pharmaceutical Industries Ltd. - Segment focus; 12.16 Thermo Fisher Scientific Inc.; Exhibit 157: Thermo Fisher Scientific Inc. - Overview; Exhibit 158: Thermo Fisher Scientific Inc. - Business segments; Exhibit 159: Thermo Fisher Scientific Inc. - Key news; Exhibit 160: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 161: Thermo Fisher Scientific Inc. - Segment focus; 12.17 Tokyo Chemical Industry Co. Ltd.; Exhibit 162: Tokyo Chemical Industry Co. Ltd. - Overview; Exhibit 163: Tokyo Chemical Industry Co. Ltd. - Product / Service; Exhibit 164: Tokyo Chemical Industry Co. Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 165: Inclusions checklist; Exhibit 166: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 167: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 168: Research methodology; Exhibit 169: Validation techniques employed for market sizing; Exhibit 170: Information sources; 13.5 List of abbreviations; Exhibit 171: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global raloxifene hydrochloride market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on End-user - Market share 2023-2028 (%); Exhibits31: Data Table on End-user - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Pharmaceutical - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Pharmaceutical - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Pharmaceutical - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Pharmaceutical - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Chemical industry - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Chemical industry - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Chemical industry - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Chemical industry - Year-over-year growth 2023-2028 (%); Exhibits42: Market opportunity by End-user ($ million); Exhibits43: Data Table on Market opportunity by End-user ($ million); Exhibits44: Chart on Type - Market share 2023-2028 (%); Exhibits45: Data Table on Type - Market share 2023-2028 (%); Exhibits46: Chart on Comparison by Type; Exhibits47: Data Table on Comparison by Type; Exhibits48: Chart on Tablet - Market size and forecast 2023-2028 ($ million); Exhibits49: Data Table on Tablet - Market size and forecast 2023-2028 ($ million); Exhibits50: Chart on Tablet - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on Tablet - Year-over-year growth 2023-2028 (%); Exhibits52: Chart on Capsule - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Capsule - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Capsule - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Capsule - Year-over-year growth 2023-2028 (%); Exhibits56: Market opportunity by Type ($ million); Exhibits57: Data Table on Market opportunity by Type ($ million); Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits61: Chart on Geographic comparison; Exhibits62: Data Table on Geographic comparison; Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits99: Market opportunity By Geographical Landscape ($ million); Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits101: Impact of drivers and challenges in 2023 and 2028; Exhibits102: Overview on Criticality of inputs and Factors of differentiation; Exhibits103: Overview on factors of disruption; Exhibits104: Impact of key risks on business; Exhibits105: Vendors covered; Exhibits106: Matrix on vendor position and classification; Exhibits107: Amneal Pharmaceuticals Inc. - Overview; Exhibits108: Amneal Pharmaceuticals Inc. - Business segments; Exhibits109: Amneal Pharmaceuticals Inc. - Key news; Exhibits110: Amneal Pharmaceuticals Inc. - Key offerings; Exhibits111: Amneal Pharmaceuticals Inc. - Segment focus; Exhibits112: Blanver - Overview; Exhibits113: Blanver - Product / Service; Exhibits114: Blanver - Key offerings; Exhibits115: Cadila Pharmaceuticals Ltd. - Overview; Exhibits116: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibits117: Cadila Pharmaceuticals Ltd. - Key offerings; Exhibits118: Cipla Ltd. - Overview; Exhibits119: Cipla Ltd. - Business segments; Exhibits120: Cipla Ltd. - Key news; Exhibits121: Cipla Ltd. - Key offerings; Exhibits122: Cipla Ltd. - Segment focus; Exhibits123: Dr Reddys Laboratories Ltd. - Overview; Exhibits124: Dr Reddys Laboratories Ltd. - Business segments; Exhibits125: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits126: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits127: Eli Lilly and Co. - Overview; Exhibits128: Eli Lilly and Co. - Product / Service; Exhibits129: Eli Lilly and Co. - Key news; Exhibits130: Eli Lilly and Co. - Key offerings; Exhibits131: Enzo Biochem Inc. - Overview; Exhibits132: Enzo Biochem Inc. - Business segments; Exhibits133: Enzo Biochem Inc. - Key offerings; Exhibits134: Enzo Biochem Inc. - Segment focus; Exhibits135: Glenmark Pharmaceuticals Ltd. - Overview; Exhibits136: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibits137: Glenmark Pharmaceuticals Ltd. - Key offerings; Exhibits138: Merck KGaA - Overview; Exhibits139: Merck KGaA - Business segments; Exhibits140: Merck KGaA - Key news; Exhibits141: Merck KGaA - Key offerings; Exhibits142: Merck KGaA - Segment focus; Exhibits143: Midas Pharma GmbH - Overview; Exhibits144: Midas Pharma GmbH - Product / Service; Exhibits145: Midas Pharma GmbH - Key offerings; Exhibits146: Santa Cruz Biotechnology Inc. - Overview; Exhibits147: Santa Cruz Biotechnology Inc. - Product / Service; Exhibits148: Santa Cruz Biotechnology Inc. - Key offerings; Exhibits149: Taj Pharmaceutical Ltd. - Overview; Exhibits150: Taj Pharmaceutical Ltd. - Product / Service; Exhibits151: Taj Pharmaceutical Ltd. - Key offerings; Exhibits152: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits153: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits154: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits155: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits156: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits157: Thermo Fisher Scientific Inc. - Overview; Exhibits158: Thermo Fisher Scientific Inc. - Business segments; Exhibits159: Thermo Fisher Scientific Inc. - Key news; Exhibits160: Thermo Fisher Scientific Inc. - Key offerings; Exhibits161: Thermo Fisher Scientific Inc. - Segment focus; Exhibits162: Tokyo Chemical Industry Co. Ltd. - Overview; Exhibits163: Tokyo Chemical Industry Co. Ltd. - Product / Service; Exhibits164: Tokyo Chemical Industry Co. Ltd. - Key offerings; Exhibits165: Inclusions checklist; Exhibits166: Exclusions checklist; Exhibits167: Currency conversion rates for US$; Exhibits168: Research methodology; Exhibits169: Validation techniques employed for market sizing; Exhibits170: Information sources; Exhibits171: List of abbreviations